EW Edwards Lifesciences Corp - 8-K

Filed Apr 23, 2026. See issuer overview · financials · original on SEC.gov ↗

Accession

0001099800-26-000021

2.029.01

Item 2.02 - Results of Operations and Financial Condition

Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.

Item 2.02.                                        Results of Operations and Financial Condition.

On April 23, 2026, Edwards Lifesciences Corporation, a Delaware corporation (“Edwards”), issued a press release setting forth Edwards’ financial results for the first quarter of 2026. A copy of the press release is furnished as Exhibit 99.1, and is incorporated herein by reference.

The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended.

Item 9.01 - Financial Statements and Exhibits

38 words

Item 9.01.                                        Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press release, dated April 23, 2026, reporting Edwards’ financial results for the first quarter of 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

2